CCC publication: CAcTUS: A parallel arm, biomarker driven, phase II feasibility trial to determine the role of circulating tumor DNA in guiding a switch between targeted therapy and immune therapy in patients with advanced cutaneous melanoma

Citation: Journal of Clinical Oncology. 2021, 39(15)
Author: Lee R.; Rothwell D.G.; Chow S.; May Shaw H.; Turajlic S.; Smith N.; Clipson A.; Clarke H.; Kelso N.; Mitchell J.; Sutton C.; Sylvestre G.; Nathan P.D.; Larkin J.; Corrie P.G.; Plummer E.R.; Marais R.; Dive C.; Lorigan P.